We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Injection of insanity

29 August 2016 By Richard Beales

The $23 bln pharma group, under fire for raising prices, is launching generics identical to its branded anti-allergy injectors at half the price. The unusual move raises questions about Mylan’s motives. Even if they’re genuine, it’s an indictment of a byzantine market structure.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)